Works matching IS 09612033 AND DT 2018 AND VI 27 AND IP 13

Results: 24

Skin signs in juvenile- and adult-onset systemic lupus erythematosus: clues to different systemic involvement.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2069, doi. 10.1177/0961203318805851

By:

Chottawornsak, N.;
Rodsaward, P.;
Suwannachote, S.;
Rachayon, M.;
Rattananupong, T.;
Deekajorndech, T.;
Asawanonda, P.;
Chiewchengchol, D.;
Rerknimitr, P.

Publication type:

Article

Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2120, doi. 10.1177/0961203318805849

By:

Luo, W.;
Mao, P.;
Zhang, L.;
Yang, Z.

Publication type:

Article

Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2129, doi. 10.1177/0961203318805844

By:

Williams, J. N.;
Chang, S-C;
Sinnette, C.;
Malspeis, S.;
Parks, C. G.;
Karlson, E. W.;
Fraser, P.;
Costenbader, K.

Publication type:

Article

Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2161, doi. 10.1177/0961203318804922

By:

Barbado, J.;
Tabera, S.;
Sánchez, A.;
García-Sancho, J.

Publication type:

Article

Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2041, doi. 10.1177/0961203318804899

By:

Noris-García, E.;
Arce, S.;
Nardin, P.;
Lanigan, M. E.;
Acuña, V.;
Gutierrez, F.;
Robinson-Agramonte, M. A.;
Gonçalves, C-A

Publication type:

Article

The blood–brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren’s syndrome.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2101, doi. 10.1177/0961203318804895

By:

Lauvsnes, M. B.;
Tjensvoll, A. B.;
Maroni, S. S.;
Kvivik, I.;
Grimstad, T.;
Greve, O. J.;
Harboe, E.;
Gøransson, L. G.;
Putterman, C.;
Omdal, R.

Publication type:

Article

Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2050, doi. 10.1177/0961203318804883

By:

Lim, S. Y.;
Bae, E. H.;
Han, K-D;
Jung, J-H;
Choi, H. S.;
Kim, H. Y.;
Kim, C. S.;
Ma, S. K.;
Kim, S. W.

Publication type:

Article

GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2112, doi. 10.1177/0961203318804894

By:

Mosaad, Y. M.;
Hammad, A.;
Elghzaly, A. A.;
Tawhid, Z. M. E.;
Hammad, E. M.;
Showma, A.;
Abdelsalam, R.;
Elmoughy, A.;
Fawzy, I. M.;
Anber, N.

Publication type:

Article

Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2086, doi. 10.1177/0961203318804891

By:

Gunashekar, S.;
Prakash, M.;
Minz, R. W.;
Sharma, A.;
Sharma, S.;
Dhir, V.

Publication type:

Article

Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2076, doi. 10.1177/0961203318804877

By:

Wu, Q.;
Yang, Q.;
Sun, H.

Publication type:

Article

Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2146, doi. 10.1177/0961203318804889

By:

Chang, J. C.;
Xiao, R.;
Mercer-Rosa, L.;
Knight, A. M.;
Weiss, P. F.

Publication type:

Article

Therapeutic response to glucocorticoids, anticoagulation and plasma exchange in a patient with primary antiphospholipid syndrome presenting with purpura fulminans.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2170, doi. 10.1177/0961203318804884

By:

Plüß, M.;
Zeisberg, M.;
Müller, G. A.;
Vasko, R.;
Korsten, P.

Publication type:

Article

Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2093, doi. 10.1177/0961203318804892

By:

Miyawaki, Y.;
Sada, K.;
Asano, Y.;
Hayashi, K.;
Yamamura, Y.;
Hiramatsu, S.;
Ohashi, K.;
Morishita, M.;
Watanabe, H.;
Matsumoto, Y.;
Kawabata, T.;
Wada, J.

Publication type:

Article

Increased CD4+CD25-Foxp3+ T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2057, doi. 10.1177/0961203318804881

By:

Yin, Z-J;
Ju, B-M;
Zhu, L.;
Hu, N.;
Luo, J.;
He, M.;
Feng, X-Y;
Lv, X-H;
Pu, D.;
He, L.

Publication type:

Article

The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2135, doi. 10.1177/0961203318804879

By:

Peterknecht, E.;
Keasey, M. P.;
Beresford, M. W.

Publication type:

Article

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2029, doi. 10.1177/0961203318804885

By:

Vincent, F. B.;
Kandane-Rathnayake, R.;
Hoi, A. Y.;
Slavin, L.;
Godsell, J. D.;
Kitching, A. R.;
Harris, J.;
Nelson, C. L.;
Jenkins, A. J.;
Chrysostomou, A.;
Hibbs, M. L.;
Kerr, P. G.;
Rischmueller, M.;
Mackay, F.;
Morand, E. F.

Publication type:

Article

Pathogenic role of antiphospholipid antibodies: an update.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2012, doi. 10.1177/0961203318802016

By:

Fujieda, Y.;
Amengual, O.;
Atsumi, T.

Publication type:

Article

Clinical predictors of active LN development in children – evidence from the UK JSLE Cohort Study.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2020, doi. 10.1177/0961203318801526

By:

Smith, E. M. D.;
Yin, P.;
Jorgensen, A. L.;
Beresford, M. W.

Publication type:

Article

New-onset lupus nephritis after male-to-female sex reassignment surgery.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2166, doi. 10.1177/0961203318800571

By:

Pontes, L. T.;
Camilo, D. T.;
De Bortoli, M. R.;
Santos, R. S. S.;
Luchi, W. M.

Publication type:

Article

The Src homology and collagen A (ShcA) adaptor protein may participate in the pathogenesis of membranous lupus nephritis.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2014, doi. 10.1177/0961203318796295

By:

Cao, W.;
Liu, X.;
Xu, X.;
Zeng, M.;
Sun, B.;
Yu, X.;
Wang, N.;
Mao, H.;
Zhang, B.;
Yuan, Y.;
Xing, C.

Publication type:

Article

Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2003, doi. 10.1177/0961203318796293

By:

Nguyen, M. H.;
Bryant, K.;
O'Neill, S. G.

Publication type:

Article

The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2177, doi. 10.1177/0961203318796289

By:

Zuo, Y.;
Udupa, A.;
Fan, J.;
Makris, U. E.;
Karp, D. R.;
Shen, Y-M

Publication type:

Article

An imbalance in the T-helper phenotypes displayed by senescent CD4+CD28null T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 13, p. 2155, doi. 10.1177/0961203318793715

By:

Lozada-Navarro, A. C.;
Castillo-Martínez, D.;
Moreno-Ramírez, M.;
Acosta-Peña, G.;
Páez, A.;
Massó, F.;
Márquez-Velasco, R.;
Amezcua-Guerra, L. M.

Publication type:

Article

Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus.

Published in:

2018

By:

Choi, Y. J.;
Yoo, W. H.

Publication type:

Case Study

Works matching IS 09612033 AND DT 2018 AND VI 27 AND IP 13

Skin signs in juvenile- and adult-onset systemic lupus erythematosus: clues to different systemic involvement.

Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis.

Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women.

Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis.

Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous.

The blood–brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren’s syndrome.

Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.

GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound.

Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.

Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

Therapeutic response to glucocorticoids, anticoagulation and plasma exchange in a patient with primary antiphospholipid syndrome presenting with purpura fulminans.

Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.

Increased CD4<sup>+</sup>CD25<sup>-</sup>Foxp3<sup>+</sup> T cells in Chinese systemic lupus erythematosus: correlate with disease activity and organ involvement.

The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Pathogenic role of antiphospholipid antibodies: an update.

Clinical predictors of active LN development in children – evidence from the UK JSLE Cohort Study.

New-onset lupus nephritis after male-to-female sex reassignment surgery.

The Src homology and collagen A (ShcA) adaptor protein may participate in the pathogenesis of membranous lupus nephritis.

Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature.

The role of cardiovascular disease risk assessed by ASCVD score in primary thrombosis prophylaxis strategy among antiphospholipid antibody carriers.

An imbalance in the T-helper phenotypes displayed by senescent CD4<sup>+</sup>CD28<sup>null</sup> T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus.

Pyoderma gangrenosum masquerading as an ulcer related to antiphospholipid antibodies in a patient with systemic lupus erythematosus.